Skip to content
Black Friday — 30% OFFFree shipping on orders of A$99 or more
  1. Home
  2. Hormonal Health & Growth
  3. Gonadorelin 2mg
Hormonal Health

Gonadorelin 2mg

Gonadorelin (synthetic GnRH/LHRH) is a synthetic decapeptide identical in sequence to the endogenous hypothalamic gonadotropin-releasing hormone.

Presentation: Gonadorelin 2mg.

Select the required strength and pack size.

Illustrative packaging generated with AI.

Presentation
Original price was: A$249.50.Current price is: A$174.65.

Available on request in Australia

Ask an advisor
An advisor contacts you and the partner pharmacy checks whether and how it can proceed. A valid prescription, or an assessment through an authorised telemedicine service, may be required.
  • Partner pharmacy
  • Personal assistance
  • Discreet delivery
  • Presentation
    Gonadorelin 2mg

Shipping & Delivery

  • Normally dispatched within 24 hours of payment confirmation.
  • USPS Regular Shipping · A$11.95 · Approx. 3–5 business days
  • FedEx 2 Days Delivery · A$28.99 · Approx. 2 business days
  • FedEx Overnight Delivery · A$40.99 · Approx. 1 business day

For laboratory research only.

Not for human or veterinary use.

Composition and product details

Overview

Gonadorelin (synthetic GnRH/LHRH) is a synthetic decapeptide identical in sequence to the endogenous hypothalamic gonadotropin-releasing hormone. Pulsatile GnRH receptor (GnRHR) activation drives pulsatile LH and FSH release from pituitary gonadotrophs; continuous receptor activation produces GnRHR downregulation and gonadotropin suppression.

Research applications include GnRHR pharmacology, HPG-axis pulsatility investigation, gonadotropin secretion dynamics, and pulse-versus-continuous agonism comparison studies.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Molecular data on PubChem

Gonadorelin 2mg1 vial | KIT (10 vials)

Properties

Chemical Formula C55H75N17O13
Synonyms Luliberin, Dirigestran, Fertagyl, Gonadorelina, Gonadorelinum, Gonadotropin-releasing hormone, LH-releasing factor
Molar Mass 1,182.31 g/mol
CAS Number 33515-09-02
PubChem CID 638793
Available formats 1 vial · KIT (10 vials)
Shelf Life 36 months

Research

Gonadorelin (pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) is a synthetic decapeptide identical in sequence to endogenous gonadotropin-releasing hormone (GnRH). It functions as a full agonist of the gonadotropin-releasing hormone receptor (GnRHR), a Gq/11-coupled GPCR expressed on gonadotroph cells. Receptor activation stimulates phospholipase C signalling, resulting in IP3/DAG generation, intracellular calcium mobilization, and downstream gonadotropin-associated signalling pathways. A defining feature of GnRHR biology is its dependence on pulsatile stimulation; transient receptor activation and continuous receptor activation produce markedly different signalling outcomes due to receptor desensitization and internalization mechanisms. Because gonadorelin is structurally identical to endogenous GnRH and possesses a very short plasma half-life, it remains the reference compound for studies investigating GnRHR pharmacology, pulsatile peptide signalling, receptor regulation, gonadotroph signalling dynamics, and comparative GnRH analogue research. Supplied as lyophilized preparation (2 mg/vial). Independently third-party HPLC-tested; COA available per batch.

FAQ

Why does pulsatile GnRH stimulate receptor signalling while continuous GnRH produces receptor desensitisation?

GnRHR is a Gq/11-coupled receptor whose signalling output is highly dependent on the pattern of ligand exposure. Intermittent receptor activation allows signalling pathways to reset between stimulation events, maintaining receptor availability and responsiveness.

In contrast, continuous receptor occupancy promotes receptor phosphorylation, β-arrestin recruitment, internalisation, and desensitisation mechanisms that reduce subsequent signalling capacity.

This pulse-frequency dependence is a defining characteristic of GnRHR biology and makes gonadorelin an important research tool for investigating receptor regulation, signal-transduction dynamics, and temporal control of GPCR signalling.

How does gonadorelin differ from long-acting GnRH analogues in research applications?

Gonadorelin is the native GnRH decapeptide and serves as the reference compound for studies of physiological GnRHR activation. Long-acting GnRH analogues incorporate structural modifications that increase receptor affinity, enzymatic stability, and duration of action.

As a result, gonadorelin is typically used when investigating acute receptor activation, pulsatile signalling dynamics, and endogenous GnRH pathway biology, whereas longer-acting analogues are valuable tools for studying receptor desensitisation, sustained receptor occupancy, and long-duration GnRHR signalling mechanisms.

Why is gonadorelin considered the reference compound for GnRHR pharmacology?

Because gonadorelin is structurally identical to endogenous GnRH, it provides the benchmark against which synthetic GnRH analogues are compared. Its receptor-binding properties, signalling characteristics, and pharmacological profile have been extensively characterised, making it a standard tool for studies of GnRHR activation, receptor regulation, signalling kinetics, ligand-receptor interactions, and comparative GnRH analogue pharmacology.

Original price was: A$249.50.Current price is: A$174.65.